The fimaNAc technology provides a targeted intracellular delivery technology for nucleic acid therapeutics. Several forms of nucleic acids are widely acknowledged to have a large potential as therapeutic agents, and numerous clinical trials are underway. The therapeutic potential of such compounds is challenged by the obstacles to achieve adequate intracellular access, which the fimaNAc technology may resolve.